6 news items
Alnylam Issues 2023 Corporate Responsibility Report
ALNY
7 May 24
and engage with us on X (formerly Twitter
Alnylam Pharmaceuticals Reports First Quarter 2024 Financial Results and Highlights Recent Period Activity
ALNY
2 May 24
and engage
Alnylam Presents Positive Results from the KARDIA-2 Phase 2 Study of Zilebesiran Added to Standard of Care Antihypertensives in Patients with Inadequately Controlled Hypertension
ALNY
7 Apr 24
and engage
Alnylam to Webcast Investor Event to Discuss Results from KARDIA-2 Phase 2 Study of Zilebesiran at American College of Cardiology Scientific Session
ALNY
20 Mar 24
and engage
Alnylam Launches Hereditary ATTR (hATTR) Amyloidosis Campaign to Help Shorten Time to Diagnosis for Inherited and Rapidly Progressive Disease
ALNY
13 Mar 24
and on their entire family," said Tiffany Patrick, MPH, MBA, Vice President, Patient Advocacy and Engagement at Alnylam Pharmaceuticals
ymxos59dl54ki4ahw
ALNY
11 Mar 24
officers and/or directors have engaged in securities fraud or other unlawful business practices
- Prev
- 1
- Next